State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 139 actively recruiting studies with Kansas sites out of 139 registered in total. The busiest research areas in Kansas are Obesity, Acute Myeloid Leukemia, Hypertension. Leading sponsors running trials in the state include University of Kansas Medical Center, SWOG Cancer Research Network, AstraZeneca. By stage, Kansas trials break down as Phase 1 (24), Phase 2 (45), Phase 3 (50), Phase 4 (4).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 139 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 139. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Obesity, Acute Myeloid Leukemia, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT07112924 N/A
Recruiting
CCM OPEN HF Registry
Condition
Heart Failure
Enrollment
5,500 pts
Location
United States
Sponsor
Impulse Dynamics
NCT05655182 Phase 1, Phase 2
Recruiting
A Study of BLB-201 RSV Vaccine in Infants and Children
Condition
Respiratory Syncytial Virus Infections
Enrollment
137 pts
Location
United States
Sponsor
Blue Lake Biotechnology Inc.
NCT06264180 Phase 3
Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on A...
Condition
Advanced Melanoma
Enrollment
400 pts
Location
United States, France, Germany
Sponsor
Replimune, Inc.
NCT06919003 Phase 2
Recruiting
Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Inje...
Condition
Kidney Transplant
Enrollment
180 pts
Location
United States
Sponsor
National Institute of Allergy
NCT04715022 Phase 1, Phase 2
Recruiting
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C St...
Condition
Hypertension
Enrollment
23 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT05869812 Phase 2
Recruiting
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative ...
Condition
Atrophy
Enrollment
30 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06318169 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Enrollment
1,350 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
NCT04864054 Phase 1, Phase 2
Recruiting
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Condition
Hepatocellular Carcinoma
Enrollment
60 pts
Location
United States, Taiwan
Sponsor
Eureka Therapeutics Inc.
NCT07088926 Phase 2
Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in P...
Condition
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Enrollment
435 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07071831 N/A
Recruiting
RETRO Study (RETrograde Renal Access Outcomes)
Condition
Renal Stones
Enrollment
150 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06917911 Phase 2
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatm...
Condition
Core Binding Factor Acute Myeloid Leukemia
Enrollment
162 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07743450 Phase 3
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Pa...
Condition
Obesity
Enrollment
1,560 pts
Location
United States, Czechia, Germany
Sponsor
Ascletis Pharma (China) Co., L
NCT07296835 N/A
Recruiting
Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ur...
Condition
Kidney Stones
Enrollment
75 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT05889650 N/A
Recruiting
External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial
Condition
Severe Traumatic Brain Injury
Enrollment
30 pts
Location
United States
Sponsor
Brain Trauma Foundation
NCT04467723 Phase 1, Phase 2
Recruiting
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
Condition
NSCLC Stage IV
Enrollment
25 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated ...
Condition
Solid Tumors
Enrollment
170 pts
Location
United States, Australia, Belgium
Sponsor
Mirati Therapeutics Inc.
NCT06527222 Phase 2
Recruiting
A Study of Ranolazine in ALS
Condition
Amyotrophic Lateral Sclerosis
Enrollment
72 pts
Location
United States
Sponsor
Swathy Chandrashekhar, MBBS
NCT05102019 N/A
Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Condition
Refractory Angina
Enrollment
380 pts
Location
United States, Canada, United Kingdom
Sponsor
Shockwave Medical, Inc.
NCT06163534 N/A
Recruiting
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Tempus AI
NCT07195409 N/A
Recruiting
Data Coaching Process to Address Staff Physical Activity Promoting Behavior and ...
Condition
Physical Activity
Enrollment
80 pts
Location
United States
Sponsor
Kansas State University
NCT07069400 N/A
Recruiting
An International Observational Study of Adults With Acute Infection
Condition
Infectious Disease
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
University of Minnesota
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT05390892 Phase 4
Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Condition
Type2Diabetes
Enrollment
6,000 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT05642611 Phase 3
Recruiting
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemo...
Condition
Malignant Solid Neoplasm
Enrollment
777 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06830798 Phase 3
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the ...
Condition
Delayed Graft Function
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Alexion Pharmaceuticals, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology